000 01481 a2200397 4500
005 20250515151818.0
264 0 _c20090127
008 200901s 0 0 eng d
022 _a0020-7314
024 7 _a10.2190/HS.38.4.i
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBaker, Dean
245 0 0 _aThe benefits and savings from publicly funded clinical trials of prescription drugs.
_h[electronic resource]
260 _bInternational journal of health services : planning, administration, evaluation
_c2008
300 _a731-50 p.
_bdigital
500 _aPublication Type: Evaluation Study; Journal Article
650 0 4 _aAccess to Information
650 0 4 _aBias
650 0 4 _aClinical Trials as Topic
_xeconomics
650 0 4 _aConflict of Interest
650 0 4 _aCosts and Cost Analysis
650 0 4 _aDrug Approval
_xeconomics
650 0 4 _aDrug Evaluation
_xeconomics
650 0 4 _aDrug Industry
650 0 4 _aDrugs, Investigational
650 0 4 _aEfficiency, Organizational
650 0 4 _aFinancing, Government
_xmethods
650 0 4 _aHumans
650 0 4 _aPatents as Topic
650 0 4 _aPolitics
650 0 4 _aResearch Support as Topic
_xmethods
650 0 4 _aUnited States
650 0 4 _aUnited States Food and Drug Administration
773 0 _tInternational journal of health services : planning, administration, evaluation
_gvol. 38
_gno. 4
_gp. 731-50
856 4 0 _uhttps://doi.org/10.2190/HS.38.4.i
_zAvailable from publisher's website
999 _c18522240
_d18522240